Global Retirement Partners LLC boosted its holdings in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 135.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,568 shares of the company’s stock after buying an additional 1,477 shares during the period. Global Retirement Partners LLC’s holdings in HCA Healthcare were worth $1,199,000 as of its most recent SEC filing.
Other hedge funds also recently bought and sold shares of the company. Palisade Asset Management LLC acquired a new stake in HCA Healthcare in the third quarter worth $26,000. Holos Integrated Wealth LLC acquired a new stake in HCA Healthcare in the fourth quarter worth $29,000. Ares Financial Consulting LLC acquired a new stake in shares of HCA Healthcare during the fourth quarter worth $31,000. Aventura Private Wealth LLC acquired a new stake in shares of HCA Healthcare during the fourth quarter worth $34,000. Finally, Key Capital Management INC acquired a new stake in shares of HCA Healthcare during the fourth quarter worth $35,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.
HCA Healthcare Price Performance
Shares of HCA opened at $394.40 on Monday. The firm has a 50-day moving average of $465.16 and a 200-day moving average of $483.77. HCA Healthcare, Inc. has a one year low of $330.00 and a one year high of $556.52. The company has a market cap of $87.49 billion, a PE ratio of 13.56, a price-to-earnings-growth ratio of 1.25 and a beta of 1.18.
HCA Healthcare Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be paid a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.73%.
Analyst Ratings Changes
A number of equities research analysts recently commented on HCA shares. KeyCorp dropped their price objective on shares of HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating on the stock in a report on Monday, April 27th. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of HCA Healthcare from $558.00 to $540.00 and set a “buy” rating on the stock in a report on Tuesday, April 28th. Argus decreased their target price on shares of HCA Healthcare from $560.00 to $500.00 and set a “buy” rating for the company in a research report on Monday, May 4th. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of HCA Healthcare in a research report on Wednesday, March 4th. Finally, Oppenheimer decreased their target price on shares of HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating for the company in a research report on Monday, April 27th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $515.77.
Get Our Latest Research Report on HCA
HCA Healthcare Company Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Recommended Stories
- Five stocks we like better than HCA Healthcare
- The Smart Glasses Gold Rush Is Leaving Old-School Eyewear Behind
- 3 Rare Earth Stocks That Win No Matter What China Does Next
- Amylyx Stock: Why the Full Pipeline Story Matters
- Palantir and Dell Build an AI OS for the Paranoid
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
